Correlation Between Dupont De and Arrowhead Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Dupont De and Arrowhead Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dupont De and Arrowhead Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Dupont De Nemours and Arrowhead Pharmaceuticals, you can compare the effects of market volatilities on Dupont De and Arrowhead Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dupont De with a short position of Arrowhead Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dupont De and Arrowhead Pharmaceuticals.

Diversification Opportunities for Dupont De and Arrowhead Pharmaceuticals

-0.37

Correlation Coefficient

Dupont De  Arrowhead Pharmaceuticals

Very good diversification

The 3 months correlation between Dupont and Arrowhead is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Dupont De Nemours and Arrowhead Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arrowhead Pharmaceuticals and Dupont De is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dupont De Nemours are associated (or correlated) with Arrowhead Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arrowhead Pharmaceuticals has no effect on the direction of Dupont De i.e., Dupont De and Arrowhead Pharmaceuticals go up and down completely randomly.

Pair Corralation between Dupont De and Arrowhead Pharmaceuticals

Allowing for the 90-day total investment horizon Dupont De is expected to generate 7.11 times less return on investment than Arrowhead Pharmaceuticals. But when comparing it to its historical volatility, Dupont De Nemours is 3.35 times less risky than Arrowhead Pharmaceuticals. It trades about 0.03 of its potential returns per unit of risk. Arrowhead Pharmaceuticals is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  2,291  in Arrowhead Pharmaceuticals on August 31, 2024 and sell it today you would earn a total of  324.00  from holding Arrowhead Pharmaceuticals or generate 14.14% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Dupont De Nemours  vs.  Arrowhead Pharmaceuticals

Dupont De Nemours

Risk-Adjusted Performance

2 of 100

Very Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Dupont De Nemours are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound fundamental indicators, Dupont De is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.

Arrowhead Pharmaceuticals

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Arrowhead Pharmaceuticals are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Even with relatively unsteady basic indicators, Arrowhead Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Dupont De and Arrowhead Pharmaceuticals

The main advantage of trading using opposite Dupont De and Arrowhead Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dupont De position performs unexpectedly, Arrowhead Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arrowhead Pharmaceuticals will offset losses from the drop in Arrowhead Pharmaceuticals' long position.

The idea behind Dupont De Nemours and Arrowhead Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.